Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus - PubMed (original) (raw)
Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus
Junko Arikawa et al. J Invest Dermatol. 2002 Aug.
Free article
Abstract
The stratum corneum of the skin of patients with atopic dermatitis is highly susceptible to colonization by various bacteria, including Staphylococcus aureus. The defense system of the skin against bacterial invasion appears to be significantly disrupted in atopic dermatitis skin, but little is known about the defense mechanism(s) involved. As one sphingolipid metabolite, sphingosine is known to exert a potent antimicrobial effect on S. aureus at physiologic levels, and it may play a significant role in bacterial defense mechanisms of healthy normal skin. Because of the altered ceramide metabolism in atopic dermatitis, the possible alteration of sphingosine metabolism might be associated with the acquired vulnerability to colonization by S. aureus in patients with atopic dermatitis. In this study, we measured the levels of sphingosine in the upper stratum corneum from patients with atopic dermatitis, and then compared that with the colonization levels of bacteria in the same subjects. Levels of sphingosine were significantly downregulated in uninvolved and in involved stratum corneum of patients with atopic dermatitis compared with healthy controls. This decreased level of sphingosine was relevant to the increased numbers of bacteria including S. aureus present in the upper stratum corneum from the same subjects. This suggests the possibility that the increased colonization of bacteria found in patients with atopic dermatitis may result from a deficiency of sphingosine as a natural antimicrobial agent. As for the mechanism involved in the decreased production of sphingosine in atopic dermatitis, analysis of the activities of ceramidases, major sphingosine-producing enzymes, revealed that, whereas the activity of alkaline ceramidase did not differ between patients with atopic dermatitis and healthy controls, the activity of acid ceramidase was significantly reduced in patients with atopic dermatitis and this had obvious relevance to the increased colonization of bacteria in those subjects. Further, there was a close correlation between the level of sphingosines and acid ceramidase (r = 0.65, p < 0.01) or ceramides (r = 0.70, p < 0.01) in the upper stratum corneum from the same patients with atopic dermatitis. Collectively, our results suggest the possibility that vulnerability to bacterial colonization in the skin of patients with atopic dermatitis is associated with reduced levels of a natural antimicrobial agent, sphingosine, which results from decreased levels of ceramides as a substrate and from diminished activities of its metabolic enzyme, acid ceramidase.
Similar articles
- Microanalysis of an antimicrobial peptide, beta-defensin-2, in the stratum corneum from patients with atopic dermatitis.
Asano S, Ichikawa Y, Kumagai T, Kawashima M, Imokawa G. Asano S, et al. Br J Dermatol. 2008 Jul;159(1):97-104. doi: 10.1111/j.1365-2133.2008.08613.x. Epub 2008 Jul 1. Br J Dermatol. 2008. PMID: 18476959 - High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis.
Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G. Hara J, et al. J Invest Dermatol. 2000 Sep;115(3):406-13. doi: 10.1046/j.1523-1747.2000.00072.x. J Invest Dermatol. 2000. PMID: 10951276 - [Disturbances of antimicrobial lipids in atopic dermatitis].
Melnik B. Melnik B. J Dtsch Dermatol Ges. 2006 Feb;4(2):114-23. doi: 10.1111/j.1610-0387.2006.05902.x. J Dtsch Dermatol Ges. 2006. PMID: 16503938 German. - Stratum corneum pH in atopic dermatitis: impact on skin barrier function and colonization with Staphylococcus Aureus.
Rippke F, Schreiner V, Doering T, Maibach HI. Rippke F, et al. Am J Clin Dermatol. 2004;5(4):217-23. doi: 10.2165/00128071-200405040-00002. Am J Clin Dermatol. 2004. PMID: 15301569 Review.
Cited by
- Gut symbiont-derived sphingosine modulates vector competence in Aedes mosquitoes.
Sun X, Wang Y, Yuan F, Zhang Y, Kang X, Sun J, Wang P, Lu T, Sae Wang F, Gu J, Wang J, Xia Q, Zheng A, Zou Z. Sun X, et al. Nat Commun. 2024 Sep 19;15(1):8221. doi: 10.1038/s41467-024-52566-1. Nat Commun. 2024. PMID: 39300135 Free PMC article. - The Pseudomonas aeruginosa sphBC genes are important for growth in the presence of sphingosine by promoting sphingosine metabolism.
DiGianivittorio P, Hinkel LA, Mackinder JR, Schutz K, Klein EA, Wargo MJ. DiGianivittorio P, et al. bioRxiv [Preprint]. 2024 Sep 3:2024.09.03.611043. doi: 10.1101/2024.09.03.611043. bioRxiv. 2024. PMID: 39282278 Free PMC article. Preprint. - Isolation of the novel phage SAP71 and its potential use against Staphylococcus aureus in an atopic dermatitis mouse model.
Geng H, Yang X, Zou C, Zhang W, Xiang J, Yang K, Shu Y, Luan G, Jia X, Lu M. Geng H, et al. Virus Genes. 2024 Sep 5. doi: 10.1007/s11262-024-02106-2. Online ahead of print. Virus Genes. 2024. PMID: 39235696 - Microbiome: Role in Inflammatory Skin Diseases.
Zhang XE, Zheng P, Ye SZ, Ma X, Liu E, Pang YB, He QY, Zhang YX, Li WQ, Zeng JH, Guo J. Zhang XE, et al. J Inflamm Res. 2024 Feb 15;17:1057-1082. doi: 10.2147/JIR.S441100. eCollection 2024. J Inflamm Res. 2024. PMID: 38375021 Free PMC article. Review. - Bacterial Metabolites and Inflammatory Skin Diseases.
Jiminez V, Yusuf N. Jiminez V, et al. Metabolites. 2023 Aug 17;13(8):952. doi: 10.3390/metabo13080952. Metabolites. 2023. PMID: 37623895 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials